Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
11
×
Tags
boston blog main
11
×
life sciences
11
×
national blog main
boston top stories
clinical trials
boston
fda
national top stories
drugs
new york blog main
new york top stories
san diego blog main
san diego top stories
alnylam pharmaceuticals
biotech
patisiran
san francisco blog main
san francisco top stories
akcea therapeutics
cancer
europe blog main
europe top stories
hereditary transthyretin amyloidosis
inotersen
onpattro
rna interference
svb leerink
tafamidis
blueprint medicines
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
marc goodman
national
pfizer
raleigh-durham blog main
raleigh-durham top stories
What
fda
11
×
medicine
11
×
drug
alnylam
rna
approval
approved
cancer
new
rnai
second
ago
filing
gene
historic
interference
oks
patients
pharmaceuticals
post
puts
seek
specifically
therapeutics
time
type
uses
weight
won
afternoon
aldeyra
alkermes
alnylam’s
announced
antipsychotic
approve
approves
awaits
benefits
betting
Language
unset
Current search:
photo
×
fda
×
" boston blog main "
×
" life sciences "
×
medicine
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision